Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 2

Sponsor Class

OTHER 2NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Myeloid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 122Precursor Cell Lymphoblastic Leukemia-Lymphoma 108Myelodysplastic Syndromes 97Lymphoma, Non-Hodgkin 88Leukemia, Lymphocytic, Chronic, B-Cell 81Hodgkin Disease 81Multiple Myeloma 80Leukemia 72Lymphoma, Mantle-Cell 62Lymphoma, Follicular 58Lymphoma 55Leukemia, Myelogenous, Chronic, BCR-ABL Positive 55Myeloproliferative Disorders 52Lymphoma, B-Cell, Marginal Zone 52Lymphoma, Large B-Cell, Diffuse 48Burkitt Lymphoma 48Leukemia, Myelomonocytic, Chronic 47Congenital Abnormalities 41Hematologic Neoplasms 37Lymphoma, Large-Cell, Immunoblastic 35Leukemia, Myeloid, Accelerated Phase 34Waldenstrom Macroglobulinemia 33Leukemia, Myeloid, Chronic-Phase 33Anemia, Refractory, with Excess of Blasts 32Primary Myelofibrosis 31Blast Crisis 28Lymphoma, T-Cell, Cutaneous 27Lymphoma, Large-Cell, Anaplastic 26Leukemia, Biphenotypic, Acute 26Dendritic Cell Sarcoma, Interdigitating 26

Interventions

fludarabine 6fludarabine phosphate 5Rituximab 5Cyclophosphamide 5Busulfan 4blinatumomab 3Lenalidomide 3thymoglobulin 2Whole-Body Irradiation 2Tacrolimus 2Peripheral Blood Stem Cell Transplantation 2Mycophenolic Acid 2Methotrexate 2Melphalan 2Bone Marrow Transplantation 2Biopsy 2Bendamustine Hydrochloride 2Behavior Therapy 2Alemtuzumab 2venetoclax 1sargramostim 1romiplostim 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1lirilumab 1ibrutinib 1duvelisib 1copanlisib 1Vincristine 1Thiotepa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Leukemia, Lymphoid × Whole-Body Irradiation × Clear all
NCT03670966 2026-05-04

211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome

Fred Hutchinson Cancer Center

Phase 1/2 Recruiting
30 enrolled
Classical hematologyLymphoidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Leukemia, Lymphoid, Leukemia, Monocytic, Acute, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03970096 2026-03-12

Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)

Fred Hutchinson Cancer Center

Phase 2 Recruiting
120 enrolled
LymphoidMyeloidOther hematologic neoplasm

Leukemia, Lymphoid, Leukemia, Monocytic, Acute, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡